The ASH-Amos Institute for Medical Faculty Development

About this funding opportunity

Jump to Main Content American Society of Hematology Awards Hematology Inclusion Pathway The ASH-Amos Institute for Medical Faculty Development Award Education Publications Agenda for Nematology Research Recommendations About Us Precision Medicine Genome Editing and Gene Therapy Immunologic Treatment Research Support and Funding Meetings Careers The ASH-Amos Institute for Medical Faculty Development Award

The Amos Institute for Medical Faculty Development (AIMFD) seeks to develop future leaders who reflect a wide breadth of lived experience to inspire and mentor others, advance biomedical sciences, and transform healthcare to improve health for all people. ASH has partnered with the AIMFD on the ASH-AIMFD Award for hematology researchers.

The ASH-AIMFD Award program, part of the Hematology Inclusion Pathway program, offers four years of postdoctoral research support including an annual grant to support research activities, the support of a Scientific Advisory Group of Experts mentor, complimentary ASH membership, and a stipend to support attendance at both the ASH and award annual meetings for the continuing four years. Key Information Program Benefits

The ASH-AIMFD Award provides four years of mentored research training, a contribution toward salary and research costs, a supportive environment for professional growth and leadership training, and access to a national network of investigators in all fields of medical research. See Additional Benefit Information Research Project Options

Applicants for the ASH-AIMFD Award must have projects in hematology. Projects may be in basic/biomedical research, clinical investigation, or health services research/epidemiology. See Research Project Option Details Program Mentorship

Applicants apply in conjunction with a mentor or mentors at their local institutions. Once in the program, each awardee’s research is overseen by a member of the AIMFD’s Scientific Advisory Group of Experts whose research interests align with theirs. See Additional Mentorship Information Eligibility Requirements

Applicants must be US citizens or permanent residents, hold an MD or equivalent, or hold a PhD and work in a medical setting. Further, awardees must be able to spend at least 70% of their time in research activities. See Additional Eligibility Requirements Application Process and Required Materials

Applicants must have the support of a mentor or mentors, preferably at their home institutions, as well as institutional support. The application requires undergraduate and graduate transcripts, three letters of reference, and the answers to several questions regarding research experience and career goals. The research proposal is limited to six pages plus citations. See Additional Information on Required Materials Evaluation and Selection

Applications are evaluated on relevance to the field of hematology, potential for innovation, and the applicant’s commitment to a research career and the goals of the program. After an initial screening, a number of applicants will be invited to an interview with the full Scientific Advisory Group of Experts. See Evaluation Criteria Key Dates

Application Available August 15, 2025 Application Deadline October 23, 2025 Interviews (via video conference) January 2026 Award Notification January 2026 Award Activation 2026

Topic areas: Life Sciences and Health, Education and Training, Workforce Development, Gender Equality and Diversity.

Funding amount

This grant provides Varies in funding.

Deadline

Applications are accepted on a rolling basis; there is no single fixed deadline.

Who can apply

This opportunity is open to the following applicant types:

• Not specified by the program.

Eligibility

The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.

Agency

The ASH-Amos Institute for Medical Faculty Development is administered by American Society of Hematology (ASH), listed via American Society of Hematology.